
Biological and Pharmaceutical Bulletin p. 491 - 497 (1999)
Update date:2022-08-02
Topics:
Abdel-Hafez, Atef A.
Meselhy, Meselhy R.
Nakamura, Norio
Hattori, Masao
Watanabe, Hiroshi
Murakami, Yukihisa
El-Gendy, Mahmoud A.
Mahfouz, Nadia M.
Mohamed, Tarek A.
Seventeen thiopaeonimetabolin-I adducts were obtained as mixtures of diastereoisomers after incubation of paeoniflorin with Lactobacillus brevis in the presence of various thiols. The anticonvulsant activity of the adducts was investigated in mice using the maximal subcutaneous pentylenetetrazol seizure test and sodium valproate (1.5 mmol/kg) as a positive control. Thirteen adducts showed dose-dependent prolongation of latencies of clonic and tonic convulsions. Maximal protection against convulsions was effectively demonstrated by 8-(nhexylthio)paeonimetabolin I (8) and 8- benzoylthiopaeonimetabolin I (18) at doses of 0.125 and 0.25 mmol/kg, respectively, while 100% protection was only achieved at 0.5 mmol/kg of 8- cyclopentylthiopaeonimetabolin I and 8-(p-tolylthio)paeonimetabolin 1. The principal anticonvulsant activity of the diastereoisomers of 8 and 18 was attributed to their 7S-isomers [ED50 values of 0.09 and 0.12 mmol/kg, and protective indices of 5.0 and 4.0 for 8 (7S) and 18 (7S), respectively], while the 7R counterparts [8 (7R) and 18 (7R)] showed a muscle relaxation effect.
Contact:410-273-7300; 800-221-3953
Address:4609 Richlynn Dr., PO Box 369, Belcamp, MD, 21017-0369, USA
Nanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
Jintan City Mego Chemical Co., Ltd
Contact:+86-0519-82814387
Address:23# Dengguan Town, Jintan, Jiangsu Province, China
HANGZHOU FOREWIN PHARMA CO., LTD
Contact:+86-571-89053961
Address:hangzhou
Tianjin Anda North Industrial & Business Co.Ltd.
Contact:86-22-24999306
Address:No.11 Erwei Road,Dongli Development Area,Tianjin,China
Doi:10.1016/j.carres.2012.01.008
(2012)Doi:10.3184/030823409X393682
(2009)Doi:10.1021/jm900528d
(2009)Doi:10.1016/j.ejmech.2009.02.008
(2009)Doi:10.1016/0009-3084(94)02315-8
(1994)Doi:10.1039/c3ra46652c
(2014)